Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase 1, Open-Label Safety and Pharmacodynamic Study of RV001, an Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antagonist, Administered by Intravenous (IV) Infusion in Patients With Diabetic Macular
Brief Summary: A Phase 1 Study to evaluate the Safety of teprotumumab in Patients with Diabetic Macular Edema.